Breast Cancer New Indication: Adjuvant Abemaciclib in HR+ Breast Cancer Ulas D. Bayraktar, MD 2023-05-20
Breast Cancer New Indication: Sacituzumab Govitecan for HR+, her2 Negative Breast Cancer Ulas D. Bayraktar, MD 2023-03-15
Breast Cancer New Protocol: Pembrolizumab with Chemotherapy in Triple-Negative Breast Cancer Ulas D. Bayraktar, MD 2022-11-26
Breast Cancer New Reference: Pembrolizumab in Triple-Negative Breast Cancer Ulas D. Bayraktar, MD 2022-11-26
